ai prostate cancer screening
42% of Men’s Health Cuts Biopsies with AI
In 2023, AI-driven prostate cancer screening reduced biopsy procedures by 42% in a multicenter trial, showing that technology can spare men unnecessary invasive tests while maintaining diagnostic confidence. Hospitals must adapt protocols, staff training, and reimbursement models to integrate these tools safely. Medical Disclaimer: This article is for informational purposes